Koligo introduces KYSLECEL(TM) autologous cell therapy product
LOUISVILLE, Kentucky, Aug. 23, 2018 /PRNewswire-AsiaNet/ -- - KYSLECEL is an autologous pancreatic islet cell therapy used for TP-IAT (total pancreatectomy with islet autotransplant) to treat chronic or recurrent acute pancreatitis- Koligo to dramatically expand access to TP-IAT, a procedure that can r...
Read more https://view-release/?pr-id=74871